BTK inhibitor 13 (compound 8) is a potent and selective Bruton's tyrosine kinase (BTK) inhibitor with an IC50 value of 1.2 nM; it is used for the inhibition of BTK in research and therapeutic applications targeting BTK-related diseases such as certain cancers and autoimmune disorders.